Equitable Smoking Relapse Prevention
Key facts
- Who runs it
- Bryan W. Heckman
- Where
- Nashville, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 2 Oct 2023
- Ended
- 30 Nov 2023
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Quitbuddy
- Control
- SDoH Augmentation
- SDoH Control
- Record updated
- 8 May 2024
- Why it stopped
- Change in Principal Investigator Affilation/Role
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- At least 21 years of age
- Smoking at least 10 cigarettes per day for the past year
- Literate in English/Spanish
- Willing to make a NRT-aided quit attempt within the next week
Who cannot take part
- Current use (past 30 days) of alternative tobacco products (e.g., electronic cigarettes, smokeless tobacco) or smoking cessation medications (self-report)
- Recent (past 3 months) cardiovascular trauma: myocardial infarction, stroke (self-report)
- Pregnancy (according to urine pregnancy test)
- Breastfeeding or planning to become pregnant (self-report)
Where in United States
- Meharry Medical CollegeNashville, United States
About the trial
What the trial wants to find out
The goal of this clinical trial is to test a GPS (Global Positioning System)-enabled smartphone app (QuitBuddy) in current smokers. The main questions it aims to answer are:
Read full original descriptionShow less
* Is Quitbuddy a good treatment for quitting smoking and "staying quit"? * Will a second treatment that connects people to help for their social and financial needs improve Quitbuddy?
Participants will:
* get nicotine lozenges in the mail * check in with the study team to report on their quitting progress after 1 day, 1 week, 1 month, 2 months, 3 months, and 6 months
Researchers will compare Quitbuddy to an app made by the National Cancer Institute to see if Quitbuddy is better for helping people stay quit.
The 2 groups in the trial
- QuitbuddyTreatment being tested
Participants will be assigned to use a smartphone app (QuitBuddy) that will automatically guide NRT treatment delivery through the integration of ecological momentary assessments (EMA) and GPS into personalized relapse prevention algorithms.
Treatment: Quitbuddy, SDoH Augmentation, and SDoH Control
- ControlExisting treatment, for comparison
Control is intended to approximate the real-world experience where Participants will use The National Cancer Institute's smartphone app (QuitGuide) and will self-manage NRT treatment delivery based on written instructions.
Treatment: Control, SDoH Augmentation, and SDoH Control
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Accelerating Health Equity Via Just-In-Time Adaptive Interventions (JITAIs): Scalable and High Impact mHealth Precision Smoking Relapse Prevention.
- Record updated
- 8 May 2024